{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:30:43Z","timestamp":1788107443408,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.imlet.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T11:10:10Z","timestamp":1637752210000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["IL-17A and IFN-\u03b3 are Up-regulated in CD4 and \u03b3\u03b4 T Cells in Active Behcet's Disease Patients"],"prefix":"10.1016","volume":"242","author":[{"given":"Vusala","family":"Abbasova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.imlet.2021.11.004_bib0001","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.imlet.2021.11.004_bib0002","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0003","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2005.02695.x","article-title":"Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease","volume":"139","author":"Imamura","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.imlet.2021.11.004_bib0004","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet's disease","volume":"50","author":"Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.imlet.2021.11.004_bib0005","first-page":"996","article-title":"Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet's disease","volume":"39","author":"Sugi-Ikai","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2004.02688.x","article-title":"Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease","volume":"139","author":"Nagafuchi","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.imlet.2021.11.004_bib0007","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Behcet patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.imlet.2021.11.004_bib0008","doi-asserted-by":"crossref","first-page":"CR227","DOI":"10.12659\/MSM.881720","article-title":"Expression of Th-17 and RORgammat mRNA in Behcet's Disease","volume":"17","author":"Hamzaoui","year":"2011","journal-title":"Med Sci Monit"},{"issue":"3 Suppl 77","key":"10.1016\/j.imlet.2021.11.004_bib0009","first-page":"32","article-title":"Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity","volume":"31","author":"Na","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.imlet.2021.11.004_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2011.04543.x","article-title":"Excessive CD4+ T cells co-expressing interleukin-17 and interferon-gamma in patients with Behcet's disease","volume":"168","author":"Shimizu","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.imlet.2021.11.004_bib0011","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14397595.2013.879414","article-title":"IL-22-secreting Th22 and IFN-\u03b3-secreting Th17 cells in Beh\u00e7et's disease","volume":"24","author":"Aktas Cetin","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"11","key":"10.1016\/j.imlet.2021.11.004_bib0012","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.1202677","article-title":"Role of IL-22- and TNF-alpha-producing Th22 cells in uveitis patients with Behcet's disease","volume":"190","author":"Sugita","year":"2013","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.imlet.2021.11.004_bib0013","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.imlet.2021.11.004_bib0014","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.imlet.2021.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10067-015-2966-2","article-title":"Possible association of proinflammatory cytokines including IL1beta and TNFalpha with enhanced Th17 cell differentiation in patients with Behcet's disease","volume":"35","author":"Shimizu","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0016","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.3786","article-title":"Dense genotyping of immune-related loci implicates host responses to microbial exposure in Beh\u00e7et's disease susceptibility","volume":"49","author":"Takeuchi","year":"2017","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2249.1990.tb05447.x","article-title":"The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet's syndrome","volume":"82","author":"Fortune","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.imlet.2021.11.004_bib0018","first-page":"588","article-title":"Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet's disease","volume":"19","author":"Suzuki","year":"1992","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","article-title":"Role of gammadelta T lymphocytes in the development of Behcet's disease","volume":"107","author":"Yamashita","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.imlet.2021.11.004_bib0020","doi-asserted-by":"crossref","first-page":"R262","DOI":"10.1186\/ar785","article-title":"Vgamma9\/Vdelta2 T lymphocytes in Italian patients with Behcet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease","volume":"5","author":"Triolo","year":"2003","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0021","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1601-0825.2005.01185.x","article-title":"Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation","volume":"12","author":"Freysdottir","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.imlet.2021.11.004_bib0022","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","article-title":"gammadelta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS)","volume":"118","author":"Freysdottir","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.imlet.2021.11.004_bib0023","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.4049\/jimmunol.1000600","article-title":"Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells","volume":"184","author":"Ness-Schwickerath","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.imlet.2021.11.004_bib0025","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","article-title":"Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma\/delta T cells in patients with active ankylosing spondylitis","volume":"64","author":"Kenna","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.imlet.2021.11.004_bib0026","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","article-title":"Identification of a novel proinflammatory human skin-homing V\u03b39V\u03b42 T cell subset with a potential role in psoriasis","volume":"187","author":"Laggner","year":"2011","journal-title":"J Immunol"},{"issue":"8697","key":"10.1016\/j.imlet.2021.11.004_bib0027","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0028","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","article-title":"Gammadelta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS)","volume":"118","author":"Freysdottir","year":"1999","journal-title":"Clinical and experimental immunology"},{"key":"10.1016\/j.imlet.2021.11.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/705831","article-title":"Gamma Delta (\u03b3\u03b4) T Cells and Their Involvement in Beh\u00e7et's Disease","volume":"2015","author":"Hasan","year":"2015","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clim.2008.03.513","article-title":"CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis","volume":"128","author":"Chen","year":"2008","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.imlet.2021.11.004_bib0031","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood-2011-06-363655","article-title":"Antibody-dependent anti-cytomegalovirus activity of human \u03b3\u03b4 T cells expressing CD16 (Fc\u03b3RIIIa)","volume":"119","author":"Couzi","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.imlet.2021.11.004_bib0032","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.imlet.2021.11.004_bib0033","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2009.119420","article-title":"IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population","volume":"69","author":"Jiang","year":"2010","journal-title":"Annals of the rheumatic diseases"},{"issue":"23","key":"10.1016\/j.imlet.2021.11.004_bib0034","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1073\/pnas.1017854108","article-title":"Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses","volume":"108","author":"Sarin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.imlet.2021.11.004_bib0035","doi-asserted-by":"crossref","first-page":"e17160","DOI":"10.1371\/journal.pone.0017160","article-title":"The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans","volume":"6","author":"Di Meglio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2021.11.004_bib0036","first-page":"2301","article-title":"Phenotype and functional profile of T cell expressing gamma delta receptor from patients with active Behcet's disease","volume":"21","author":"Hamzaoui","year":"1994","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.imlet.2021.11.004_bib0037","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1067\/mjd.2001.117728","article-title":"HSP 60 expression in mucocutaneous lesions of Behcet's disease","volume":"45","author":"Ergun","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.imlet.2021.11.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1186\/ar4147","article-title":"Expression of regulatory receptors on \u03b3\u03b4 T Cells and their cytokine production in Behcet's disease","volume":"15","author":"Parlakgul","year":"2013","journal-title":"Arthritis Research and Therapy"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0039","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar3043","article-title":"Phenotype and functional changes of Vgamma9\/Vdelta2 T lymphocytes in Behcet's disease and the effect of infliximab on Vgamma9\/Vdelta2 T cell expansion, activation and cytotoxicity","volume":"12","author":"Accardo-Palumbo","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.imlet.2021.11.004_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humimm.2015.10.001","article-title":"In vitro evaluation of \u03b3\u03b4 T cells regulatory function in Beh\u00e7et's disease patients and healthy controls","volume":"77","author":"Clemente Ximenis","year":"2016","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0041","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/cmi.2008.25","article-title":"Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis","volume":"5","author":"Peng","year":"2008","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"10.1016\/j.imlet.2021.11.004_bib0042","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/08820139.2017.1306865","article-title":"Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease","volume":"46","author":"Deniz","year":"2017","journal-title":"Immunol Invest"},{"key":"10.1016\/j.imlet.2021.11.004_bib0043","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2018.10.013","article-title":"Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease","volume":"201","author":"Lucherini","year":"2018","journal-title":"Immunol Lett"},{"issue":"10","key":"10.1016\/j.imlet.2021.11.004_bib0044","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.it.2012.05.004","article-title":"Defining the human T helper 17 cell phenotype","volume":"33","author":"Annunziato","year":"2012","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2011.07.008","article-title":"Regulation of TH17 and regulatory T cells in patients with Behcet disease","volume":"128","author":"Direskeneli","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.imlet.2021.11.004_bib0046","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease","volume":"128","author":"Geri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4 Suppl 60","key":"10.1016\/j.imlet.2021.11.004_bib0047","first-page":"S16","article-title":"Imbalance of Th17 to Th1 cells in Beh\u00e7et's disease","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.imlet.2021.11.004_bib0048","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.it.2011.06.007","article-title":"T helper 17 cell heterogeneity and pathogenicity in autoimmune disease","volume":"32","author":"Ghoreschi","year":"2011","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.imlet.2021.11.004_bib0049","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nature immunology"},{"issue":"8","key":"10.1016\/j.imlet.2021.11.004_bib0050","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.imlet.2021.11.004_bib0051","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-007-0367-9","article-title":"Pro-inflammatory cellular immune response in Beh\u00e7et's disease","volume":"27","author":"Kulaber","year":"2007","journal-title":"Rheumatology International"},{"issue":"7","key":"10.1016\/j.imlet.2021.11.004_bib0052","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/rheumatology\/keh195","article-title":"Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease","volume":"43","author":"Koarada","year":"2004","journal-title":"Rheumatology"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:40:23Z","timestamp":1759045223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821001802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"alternative-id":["S0165247821001802"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.11.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-17A and IFN-\u03b3 are Up-regulated in CD4 and \u03b3\u03b4 T Cells in Active Behcet's Disease Patients","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}